SCHEMBL8634916

SCHEMBL8634916

O=C(O)C(c1ccc(CCO)cc1)C1CCCC1

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CHRM3 P20309 4/20 0.47
ALOX5 P09917 2/20 0.44
HDAC6 Q9UBN7 1/20 0.44
HTR1E P28566 2/20 0.43
KMT2A Q03164 2/20 0.43
S1PR3 Q99500 2/20 0.43
MEN1 O00255 1/20 0.43
LMNA P02545 1/20 0.43
MAPT P10636 1/20 0.43
EPHX1 P07099 1/20 0.41
CYP4F2 P78329 1/20 0.40
CYP4A11 Q02928 1/20 0.40
S1PR1 P21453 1/20 0.39
PTGS1 P23219 1/20 0.39
PTGS2 P35354 1/20 0.39
OPRK1 P41145 1/20 0.39
HTT P42858 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8636307 0.91 CHRM3 (0.49) CHRM3ALOX5HDAC6HTR1EKMT2A
SCHEMBL27483589 0.86 CHRM3 (0.46) CHRM3ALOX5HDAC6HTR1EKMT2A
SCHEMBL27388408 0.86 CHRM3 (0.46) CHRM3ALOX5HDAC6HTR1EKMT2A
SCHEMBL7013582 0.83 ALOX5 (0.45) CHRM3ALOX5HDAC6HTR1EKMT2A
SCHEMBL1069660 0.83 ALOX5 (0.45) CHRM3ALOX5HDAC6HTR1EKMT2A
SCHEMBL27361339 0.83 BDKRB2 (0.48) CHRM3ALOX5HDAC6HTR1EKMT2A
SCHEMBL27368748 0.83 BDKRB2 (0.48) CHRM3ALOX5HDAC6HTR1EKMT2A
SCHEMBL10006210 0.83 NPC1 (0.46) CHRM3ALOX5HDAC6HTR1EKMT2A
SCHEMBL4242909 0.78 ALOX5 (0.49) CHRM3ALOX5HDAC6HTR1EKMT2A
SCHEMBL69127 0.78 HTR1E (0.65) CHRM3ALOX5HDAC6HTR1EKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5776964-A HYPOTENSIVE AGENTS; ANTICHOLESTEROL AGENTS; CARDIOVASCULAR DISORDERS BAYER AKTIENGESELLSCHAFT (DE) 1998-07-07 US disclosed
US-5521206-A HYPOTENSIVE AGENTS, TREATMENT OF ATHEROSCLEROSIS BAYER AKTIENGESELLSCHAFT (DE) 1996-05-28 US disclosed